In this report, we molecularly targeted OXCT1 and ACAT1, to prevent cancer cells from recycling ketone bodies into Acetyl-CoA, which normally enters the TCA cycle, driving mitochondrial ATP production. The gene discussed is OXCT1; the disease is cancer.